Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection
Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection
批准号:
10132382
负责人:
Jay D. Humphrey
金额:
$77.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-01 至 2023-03-31
关键词:
AortaAortic AneurysmAreaArterial DisorderArterial Fatty StreakAtherosclerosisAutophagocytosisBiogenesisBiomechanicsCell Culture TechniquesCell CycleCell DeathCell ProliferationCell SurvivalCell physiologyCellsChronicClinicalCollectionComplexDataDiseaseDisease ProgressionDissectionElastic FiberEndocytosisEnzymesEtiologyEventExocytosisExperimental ModelsExtracellular MatrixFRAP1 geneFunctional disorderGenesGenetic TranscriptionGoalsGrowthHandHistologicHumanInterruptionLeadLysosomesMapsMedialMedicalMedical GeneticsMedical ImagingMolecularMorbidity - disease rateMorphologyMusNamesOrganellesPathogenesisPathologicPathologyPeptide HydrolasesPhagocytosisPharmacotherapyPhenotypePhosphotransferasesProcessProductionPropertyProtein BiosynthesisProteinsProteolysisRNA markerRecyclingResearch PersonnelRoleRuptureSamplingSeverity of illnessSignal PathwaySignal TransductionSmooth Muscle MyocytesSpecimenStressStructureTSC1 geneTSC2 geneTestingThoracic Aortic AneurysmThoracic aortaTissuesTuberous sclerosis protein complexage groupcell growthdaughter cellexperimental studyextracellularhemodynamicsimprovedinhibitor/antagonistinsightmacromoleculemacrophagemortalitymouse modelnew therapeutic targetnovelpostnatalprotein biomarkerspublic health relevanceresponsesextargeted treatmenttranscription factortransdifferentiationtumor growthuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Thoracic aortic aneurysm and dissection (TAAD) are a poorly understood group of disorders responsible for
significant morbidity and mortality in both sexes and all age groups, but without specific pharmacotherapy.
Elucidation of disease mechanisms focus on conspicuous areas of medial smooth muscle cell (SMC) loss,
whereas foci of SMC proliferation are overlooked. We found that the number of SMCs is increased in clinical
specimens of TAAD, as have several other investigators. We considered that excessive SMC proliferation may
exacerbate TAAD as dividing cells transition from a contractile phenotype to enter the cell cycle and daughter
cells may interrupt interactions with contiguous elastic laminae or drive growth of the vessel wall. To test our
hypothesis that SMC proliferation and proliferative signaling contributes to aortopathy, we developed a novel
experimental model. Conditional deletion of Tsc1, a component of the tuberous sclerosis complex, in postnatal
murine SMCs leads to activation of a key kinase, mechanistic target of rapamycin (mTOR), that regulates cell
proliferation among other processes. Our preliminary studies reveal that induction of mTOR signaling and SMC
proliferation cause progressive TAAD associated with a novel "degradative phenotype" of SMCs. Our goals are
to understand cellular and molecular mechanisms of the disease process and to determine if relevant in other
experimental models and clinical specimens of TAAD. We do not believe that the acquisition of a subset of
macrophage markers and functions by degradative SMCs in the aortic media represents transdifferentiation to
macrophages as recently described in atherosclerotic plaques. Rather, degradative SMCs acquire certain
properties that mimic macrophage maturation, including increased protease secretion, phagocytosis,
endocytosis, autophagy, and lysosome activity. Greater proteolysis, together with sequelae from loss of
contractile and synthetic activity, lead to elastic fiber fragmentation and TAAD, though clearance of extracellular
debris and recycling of macromolecules may retard disease progression. Our hypothesis is provocative and our
preliminary data compelling. Completion of our proposed experiments will yield considerable insight into the
pathogenesis of TAAD and other mTOR-dependent arteriopathies, such as atherosclerosis and aortic stiffening,
and discover new therapeutic targets for this lethal disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Computational model-driven design to mitigate vein graft failure after coronary artery bypass
-
批准号:10683327
-
项目类别:
-
资助金额:$70.08万
-
财政年份:2022
-
负责人:Jay D. Humphrey
-
依托单位:
Computational model-driven design to mitigate vein graft failure after coronary artery bypass
-
批准号:10539814
-
项目类别:
-
资助金额:$75.24万
-
财政年份:2022
-
负责人:Jay D. Humphrey
-
依托单位:
Modeling Multiscale Immuno-Mechanics in Aortic Disease
-
批准号:10532786
-
项目类别:
-
资助金额:$49.18万
-
财政年份:2022
-
负责人:Jay D. Humphrey
-
依托单位:
Modeling Multiscale Immuno-Mechanics in Aortic Disease
-
批准号:10352581
-
项目类别:
-
资助金额:$50.02万
-
财政年份:2022
-
负责人:Jay D. Humphrey
-
依托单位:
Multiscale Modeling of Aortic Homeostasis
-
批准号:10471254
-
项目类别:
-
资助金额:$8.38万
-
财政年份:2021
-
负责人:Jay D. Humphrey
-
依托单位:
Multiscale Modeling of Aortic Homeostasis
-
批准号:10189114
-
项目类别:
-
资助金额:$8.38万
-
财政年份:2021
-
负责人:Jay D. Humphrey
-
依托单位:
Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection
-
批准号:10184861
-
项目类别:
-
资助金额:$7.33万
-
财政年份:2020
-
负责人:Jay D. Humphrey
-
依托单位:
Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection
-
批准号:10376852
-
项目类别:
-
资助金额:$65.28万
-
财政年份:2019
-
负责人:Jay D. Humphrey
-
依托单位:
Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection
-
批准号:10573756
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2019
-
负责人:Jay D. Humphrey
-
依托单位:
Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection
-
批准号:9904189
-
项目类别:
-
资助金额:$65.28万
-
财政年份:2019
-
负责人:Jay D. Humphrey
-
依托单位:
Multimodality imaging-driven multifidelity modeling of aortic dissection
-
批准号:9981804
-
项目类别:
-
资助金额:$60.13万
-
财政年份:2018
-
负责人:Jay D. Humphrey
-
依托单位:
Multimodality imaging-driven multifidelity modeling of aortic dissection
-
批准号:10242915
-
项目类别:
-
资助金额:$55.94万
-
财政年份:2018
-
负责人:Jay D. Humphrey
-
依托单位:
Multimodality imaging-driven multifidelity modeling of aortic dissection
-
批准号:10453465
-
项目类别:
-
资助金额:$55.94万
-
财政年份:2018
-
负责人:Jay D. Humphrey
-
依托单位:
Improving Tissue Engineered Vascular Graft Performance via Computational Modeling
-
批准号:10082302
-
项目类别:
-
资助金额:$88.23万
-
财政年份:2018
-
负责人:Jay D. Humphrey
-
依托单位:
Improving Tissue Engineered Vascular Graft Performance via Computational Modeling
-
批准号:10461485
-
项目类别:
-
资助金额:$73.13万
-
财政年份:2018
-
负责人:Jay D. Humphrey
-
依托单位:
TGFB-Dependent Mechanoresponses by Aortic Smooth Muscle Cells Govern Aneurysms
-
批准号:10378127
-
项目类别:
-
资助金额:$41.73万
-
财政年份:2018
-
负责人:Jay D. Humphrey
-
依托单位:
Core C: Computational and Experimental Biomechanical Assessment (CEBA)
-
批准号:10378123
-
项目类别:
-
资助金额:$22.22万
-
财政年份:2018
-
负责人:Jay D. Humphrey
-
依托单位:
Improving Tissue Engineered Vascular Graft Performance via Computational Modeling
-
批准号:10612079
-
项目类别:
-
资助金额:$69.22万
-
财政年份:2018
-
负责人:Jay D. Humphrey
-
依托单位:
Characterization of TGFB-Dependent Mechanoresponses by Aortic Smooth Muscle Cells
-
批准号:9380043
-
项目类别:
-
资助金额:$59.94万
-
财政年份:2017
-
负责人:Jay D. Humphrey
-
依托单位:
Genetically-altered mechanical homeostasis in central arteries
-
批准号:9208773
-
项目类别:
-
资助金额:$7.22万
-
财政年份:2016
-
负责人:Jay D. Humphrey
-
依托单位:
海外基金